Sensitivity and resistance to EGF-R inhibitors: approaches to enhance the efficacy of EGF-R antibodies.
about
7th annual European Antibody Congress 2011: November 29-December 1, 2011, Geneva, Switzerland.Complement-mediated tumor-specific cell lysis by antibody combinations targeting epidermal growth factor receptor (EGFR) and its variant III (EGFRvIII).EGFR expression levels affect the mode of action of EGFR-targeting monoclonal antibodies.
P2860
Sensitivity and resistance to EGF-R inhibitors: approaches to enhance the efficacy of EGF-R antibodies.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Sensitivity and resistance to ...... efficacy of EGF-R antibodies.
@ast
Sensitivity and resistance to ...... efficacy of EGF-R antibodies.
@en
Sensitivity and resistance to ...... efficacy of EGF-R antibodies.
@nl
type
label
Sensitivity and resistance to ...... efficacy of EGF-R antibodies.
@ast
Sensitivity and resistance to ...... efficacy of EGF-R antibodies.
@en
Sensitivity and resistance to ...... efficacy of EGF-R antibodies.
@nl
prefLabel
Sensitivity and resistance to ...... efficacy of EGF-R antibodies.
@ast
Sensitivity and resistance to ...... efficacy of EGF-R antibodies.
@en
Sensitivity and resistance to ...... efficacy of EGF-R antibodies.
@nl
P2093
P2860
P356
P1476
Sensitivity and resistance to ...... efficacy of EGF-R antibodies.
@en
P2093
Matthias Peipp
Michael Dechant
Thomas Valerius
P2860
P304
P356
10.4161/MABS.1.6.10051
P577
2009-11-11T00:00:00Z